Galderma Group’s consensus analyst price target has edged up from CHF 149.91 to CHF 150.37, reflecting analysts’ renewed optimism for the stock’s prospects. The modest adjustment follows active ...
Highlights: Commissioning and operations team fully mobilised to site at Kiniéro Gold Project as Robex prepares for first ...
ILLUSTRATION BY KIKO BUENAVENTURA This is not a prediction. It’s a trend analysis. I have been close to some of the top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback